Autosomal recessive lethal and severe osteogenesis imperfecta (OI) is caused by the deficiency of cartilageassociated protein (CRTAP) and prolyl-3-hydroxylase 1 (P3H1) because of CRTAP and LEPRE1 mutations. We analyzed five families in which 10 individuals had a clinical diagnosis of lethal and severe OI with an overmodification of collagen type I on biochemical testing and without a mutation in the collagen type I genes. CRTAP mutations not described earlier were identified in the affected individuals. Although it seems that one important feature of autosomal recessive OI due to CRTAP mutations is the higher consistency of radiological features with OI type II-B/III, differentiation between autosomal dominant and autosomal recessive OI on the basis of clinical, radiological and biochemical investigations proves difficult in the affected individuals reported here. These observations confirm that once a clinical diagnosis of OI has been made in an affected individual, biochemical testing for overmodification of collagen type I should always be combined with molecular genetic analysis of the collagen type I genes. If no mutations in the collagen type I genes are found, additional molecular genetic analysis of the CRTAP and LEPRE1 genes should follow. This approach will allow proper identification of the genetic cause of lethal or severe OI, which is important in providing prenatal diagnosis, preimplantation genetic diagnosis and estimating recurrence risk.
Introduction
Osteogenesis imperfecta (OI) was first described by the Swedish surgeon, Olaus Jakob Ekman, in a family with hereditary bone fragility (1788). 1 On account of the extreme variability in the presentation of OI, a classification into four types (OI type I (mild), II (lethal), III (severe) and IV (moderate) was introduced by Sillence et al (1979) (the 'Sillence classification')). Type II OI was further subdivided into type A, B and C on the basis of radiological features. The earlier assumption based on pedigree findings that OI type II was inherited in an autosomal recessive way shifted toward the view that OI type II was primarily inherited as an autosomal dominant disease 2 -5 with the discovery of heterozygous mutations in the collagen type I genes, COL1A1 and COL1A2, in all types of OI. In addition, it was recorded that most recurrences in OI type II and III were caused by gonadal mosaicism in one of the parents. The empirical recurrence rate of lethal OI was estimated at 6%. 6 -10 However, it seemed that not all patients with lethal or severe OI had a collagen type I mutation. 11, 12 A hypomorphic loss-of-function of CRTAP-encoding cartilage-associated protein (CRTAP) was shown to cause the rhizomelic form of moderate -severe recessive OI, originally described as OI type VII. 13, 14 Furthermore, complete loss-of-function mutations of CRTAP and of LEPRE1, which encode CRTAP and prolyl-1-hydroxylase (P3H1), seemed to cause autosomal recessive lethal and severe OI. 14, 15, 16 CRTAP, P3H1 and cyclophilin B (CyPB) encoded by PPIB form a protein complex in the rough endoplasmic reticulum (rER), which is responsible for 3-hydroxylation of proline at position 986 in the a1 chain of collagen type I. In individuals affected with lethal or severe OI due to mutations in COL1A1, COL1A2, CRTAP and LEPRE1, comparable delayed migration of collagen type I is evident, which is visible as backstreaking, increased band width or baseline shift on electrophoresis (see Figure 1 ). This phenomenon is due to posttranslational overmodification and can be explained by the structure of collagen type I, which is first synthesized as procollagen type I consisting of two proa1(I) chains and one proa2(I) chain, containing N-and C-terminal propeptides. Posttranslational modification necessary to reach intertwining of the chains resulting in triple-helical conformation takes place in the rER. Currently, two posttranslational modification systems of collagen type I are known, namely, (i) hydroxylation of multiple lysine and proline residues by lysyl hydroxylase and prolyl-4-hydroxylase and (ii) 3-hydroxylation of a single residue in the a1 chain, proline at position 986 by the protein complex in the rER, consisting of P3H1, CRTAP and CyPB. Triple-helical folding occurs in the C-to-N direction, making lysines and prolines inaccessible to posttranslational modification as soon as the chain in which they are located is folded. Posttranslational overmodification takes place when a delay in triple-helical folding results in overprocessing of the constituent collagen type I chains by the enzymes involved in posttranslational modification. This delay can be caused by collagen type 1 mutations disturbing the primary structure of collagen type I or by deficiency in two of the components of the prolyl-3-hydroxylation complex, CRTAP and P3H1 LEPRE1. 17 -20 Here, we describe 10 individuals affected with lethal or severe OI due to novel CRTAP mutations.
Materials and methods

Patients
We selected 13 individuals from seven families for screening, on the basis of clinical diagnosis of OI type II/ 
Results
In all 13 individuals from seven families, posttranslational overmodification on electrophoresis was evident. In 2 individuals from one family, LEPRE1 mutations were detected, in 1 individual no mutations in CRTAP, LEPRE1 and PPIB were detected and 10 individuals from five families appeared to have novel CRTAP mutations. Here, we describe the clinical features and mutation analysis of patients with OI due to CRTAP mutations only.
Family 1
Clinical findings The parents were consanguineous (Caucasian) and the mother was pregnant with male monozygotic twins ( Figure 2 ). An advanced ultrasound screening at 21 weeks of gestation showed bowed and short femura op5 in both fetuses (VI:3 and VI:4). In one fetus, a possible fracture of the femur was seen. Owing to the strong suspicion of OI type II/III, the pregnancy was terminated at 23 þ 2 weeks of gestation. No permission was given for autopsy. On the babygram, fractures of the femora were detected in both fetuses, with no apparent rib fractures (Supplementary Appendix Figures 3 and 4) . The fetuses were diagnosed with OI type II-B. In the following pregnancy, an advanced ultrasound in the 19th week of gestation again showed skeletal abnormalities consisting of a fracture of the femur, a bowed tibia and short osseous elements. The parents decided to proceed with the pregnancy, and a daughter (VI:5) was born by cesarean section at 39 weeks of gestation, with an Apgar score of 9, 9 and 10 after 1, 5 and 10 min, respectively. Birth weight was 3245 g. The neonate had normocephaly, a round face with shallow orbits, white sclerae, long philtrum, small thorax, rhizomelic shortening of the upper and lower extremities and abducted position of the legs ( Figure 3) . A skeletal overview showed evidence of multiple fractures ( Figure 4 ). The girl was diagnosed with OI type III and is alive at the age of 2 years.
Mutation analysis In the twin, monozygosity was confirmed by marker studies. Mutation screening of the COL1A1 and COL1A2 genes in the fetuses, VI:3 and VI:4, identified a variant, c.613 C4G; p.pro205Ala, in the COL1A1 gene. This variant has been reported in literature before and is probably associated with osteopenia. 23 Mutation analysis of the ALPL gene responsible for hypophosphatasia was negative. In the third affected child, no mutations in the COL1A1, COL1A2 and LEPRE1 genes were found.
Sequencing of the CRTAP gene in the three affected children revealed homozygosity for the mutation, c.21_22dupGG, introducing a premature termination codon at p.Ala8fs in exon 1. The parents were heterozygous for this mutation. In the fourth pregnancy, ultrasound images around the 20th week of gestation displayed skeletal abnormalities suggestive of OI. At 23 þ 2 weeks of gestation, shortened and deformed extremities, a fracture of the left femur and a bell-shaped thorax were observed on ultrasound screening. A girl (IV:4) was born at 38 þ 3 weeks. A skeletal overview showed gracile bones and multiple fractures with callus formation ( Figure 5 ). The girl died 1 week later because of respiratory insufficiency. A femur was taken for histological examination ( Figure 6 ).
Mutation analysis Fibroblast cultures of the first child became infected, and no mutations in the COL1A1, COL1A2 and LEPRE1 genes were identified in the second affected child. Sequencing of the CRTAP gene showed homozygosity for the mutation, c.404delG, introducing a premature termination codon at p.Ser135fs in exon 1 of the CRTAP gene. The parents were both heterozygous for this mutation.
Family 3
Clinical findings A caucasian girl (II:1) was born at 40 þ 6 weeks of gestation with Apgar scores of 7 and 9 at 1 and 5 min, respectively. On physical examination, fragmentation of the skull bones was observed and a short thorax with short and bowed extremities was noticed, suggesting OI. The child had no overt blue sclerae. A skeletal overview showed multiple rib fractures and fractures of both the upper and lower extremities. The neonate was diagnosed with OI type II-C/III. At the age of 2.5 months, she died due to respiratory failure.
In the following pregnancy, an ultrasound in the 17th week showed no evidence of fractured or bowed extremities. However, at 18 þ 4 weeks of gestation, fractures of both femora were observed. A recurrence of OI was suspected and the pregnancy was terminated at 20 þ 2 weeks. Multiple fractures were evident ( Figure 7 ) and the fetus (II:2) was diagnosed with OI type II (Figure 2 ). The fifth pregnancy (II:5) was terminated because of an evident posttranslational overmodification of collagen type 1 in cultured chorion villi.
Mutation analysis Mutations in the COL1A1, COL1A2
and LEPRE1 genes were not detected in the three affected children. Sequencing of the CRTAP gene showed that they were all compound heterozygous for a c.198C4A mutation predicted to result in a p.Tyr66X amino acid change in exon 1 and a c.471 þ 2 C4A splice-site change in intron 1 of the CRTAP gene. The mother was heterozygous for the c.471 þ 2 C4A mutation and the father was heterozygous for the c.198C4A mutation.
Family 4
Clinical findings At a pregnancy duration of 20 weeks, ultrasound abnormalities were observed consisting of short and bowed extremities and a short thorax. Suspecting OI, a cesarean section was carried out at 39 þ 4 weeks of gestation. A caucasian boy (II:1) was born with Apgar scores of 2 -3 and 8 -9 after 1 and 5 min, respectively. He had a large anterior fontanel, short thorax, short and bowed extremities and glandular hypospadia. A skeletal overview showed wormian bones, as well as multiple fractures of ribs and of both the upper and lower extremities ( Figure 8) . He was diagnosed with OI type III and died 5 days after birth (Figure 2 ).
Mutation analysis Mutations in the COL1A1, COL1A2
and LEPRE1 genes were not detected in the affected child. Sequencing of the CRTAP gene showed that the affected child was compound heterozygous for a splice-site mutation, c.923-2A4G, in intron 4 and for two mutations on the other allele in exon 1, namely, c.38C4A and c.469A4G. The mother was heterozygous for the c.38C4A and c.469A4G mutations in exon 1. The father was not available.
Family 5
Clinical findings In the first pregnancy, abnormalities of the extremities were observed in the fetus at 23 weeks of gestation. At the 24th week of gestation, short upper and lower extremities were observed, indicating severe skeletal dysplasia. At a gestation period of 40 þ 4 weeks, a caucasian boy (II:1) was born. He had a round face with shallow orbits, grayish sclerae, small thorax, rhizomelic shortening of the upper and lower extremities, abducted position of the legs and normocephaly (Figure 9) . A skeletal overview showed multiple fractures, suggesting OI type II/III. The child is alive at the age of 4 years ( Figure 2 ). Mutation analysis Mutations in the COL1A1, COL1A2 and LEPRE1 genes were not detected in the affected child. Sequencing of the CRTAP gene showed homozygosity for the c.471 þ 2C4A mutation in intron 1 of CRTAP.
Discussion
We describe 10 individuals with lethal or severe OI on the basis of clinical (Table 1 Supplementary Appendix), radiological (Table 1 ) and biochemical ( Figure 1 ) findings, in whom novel CRTAP mutations (Table 2) were found. So far, six probands with lethal or severe OI due to CRTAP mutations have been reported in literature. An important question is whether the phenotype of patients with lethal OI due to CRTAP mutations differs from that of patients with OI due to mutations in the collagen type I genes.
Barnes et al, 15 described in three individuals with OI due to CRTAP mutations, some clinical features in CRTAPrelated OI, which differed from the clinical features in individuals with OI due to collagen type I mutations, namely, (i) no relative macrocephaly, (ii) a round face with shallow orbits, (iii) white or grayish sclerae and (iv) rhizomelic shortening of the upper and lower extremities. Indeed, our patients, VI:5 and II:1 from family 1 and 5 depicted in Figure 3 , show no relative macrocephaly, a round face and no blue sclerae. The clinical assessments of VI:5 suggest rhizomelic shortening of the arms. However, because of the absence of sufficient clinical details of the other liveborn children with CRTAP mutations, the specificity of these clinical differences is uncertain. Therefore, a distinction between autosomal dominant OI due to collagen type I mutations and autosomal recessive OI due to CRTAP mutations on clinical features proves difficult. Radiologically, bowing of extremities and/or fractures could be observed in the prenatal and neonatal period in all our patients with CRTAP mutations. The earliest appearance of features of OI was noted in the 18th week of pregnancy (Table 1 Supplementary Appendix). However, this pregnancy was monitored extensively because of an affected sib. Recently, 'popcorn' epiphyses have been suggested to be a distinguishing radiological feature of autosomal recessive OI, reflecting a cartilaginous dysplasia at the developing growth plate. 22 However, histology of Table 1 Revised radiological features of probands with CRTAP mutations. Figure 4) . Furthermore, popcorn epiphysis has been reported in a patient with OI due to a COL1A2 mutation, and recently in other patients with OI type III and IV due to COL1A1 and COL1A2 mutations. 24, 25 Popcorn epiphyses were absent in the 4-year-old proband II:1 from family 5 (see Figure 5 Supplementary Appendix).
Considering the above, we hypothesize that popcorn calcifications reflect a disturbance of enchondral ossification, which can occur in CRTAP-related OI as well as in COL1A1/2-related OI. Importantly, on revision of the available radiographs by a pediatric radiologist, the classification of OI differed in three of the eight cases (Table 2) , which stresses the need for evaluation of radiographs by a pediatric radiologist in all cases of OI. It is interesting that a radiological diagnosis of OI type II-B or III was evident in all the affected individuals with CRTAP mutations in the literature, 15, 22 as well as in all our patients. One important difference between OI type II-A, -B and -C is the extent and manner of rib involvement. 3 In OI II-A, the ribs are very broad with contiguous fractures (contiguous beading), whereas in OI II-B, the ribs are rather small, with an irregular course and few fractures, and in OI II-C, which is very rare, varying thickness and discontinuous beading of the ribs are noted. In OI III, rib fractures are less commonly observed. Interestingly, a recurrence rate from 0% in OI II-A patients 4 to 7.7% in OI II-B patients 5 has been described. It seems that CRTAP mutations cause OI type II-B/III, and it might be that recurrence in OI type II-A is because of gonadal mosaicism of COL1A1/2 mutations only. However, OI type II-B/III can also be caused by COL1A1/2 mutations, which makes differentiation of CRTAP-related OI on the basis of radiological features difficult. On biochemical testing by electrophoresis, full overmodification of collagen type I was observed comparable with predominantly inherited lethal and severe OI due to collagen type I mutations. However, in some instances, it is possible to discriminate between autosomal recessive and predominantly inherited lethal and severe OI, as in the latter, some normal molecules can be made and chains with normal mobility can be visualized.
In the affected individuals, genomic and complementary DNA sequencing of the COL1A1 and COL1A2 genes was negative. Mutation analysis of CRTAP and LEPRE1 genes identified seven new CRTAP mutations in five families and one new homozygous LEPRE1 mutation in one family. An overview of (new) CRTAP mutations is given in Table 2 and Figure 6 of the Supplementary Appendix. Pathogenicity of the identified mutations was supported by in silico analysis. The c.21_22dupGG and c.404delC mutations in exon 1 are frameshift mutations, leading to a stop codon 6 and 39 amino acids downstream, respectively. The c.471 þ 2C4A mutation is a splice donor-site mutation that changes the second nucleotide in intron 1, which is the unusual nucleotide, C. (see Supplementary Appendix Figure 1 ). cDNA sequencing proves that this mutation causes a null allele (see Supplementary Appendix Figure 2 ). The 198C4A mutation replaces tyrosine at position 66 with a premature termination codon. It is interesting to note that II:1 from family 4 has three mutations. The c.923-2A4G mutation in intron 4 is a splice acceptor site mutation leading to disruption of the normal splicing of exon 5. The c.469A4G mutation in exon 1 and the c.38 C4A mutation reside on the same allele. The c.469A4G mutation is a non-conservative change resulting in a p.Lys157Glu amino acid change and could therefore be considered pathogenic. However, the c.38C4A missense mutation resulting in p.Ala13Glu might also be pathogenic, as it disturbs the charge distribution in the signal peptide and could lead to retainment of CRTAP in the rER. Currently, functional studies are being conducted to investigate the pathogenicity of these mutations. The c.38 C4A mutation and the c.469 A4G both reside on the maternal allele.
In conclusion, although a diagnosis of OI type II-A seems to point to autosomal dominant OI, in OI types II-B and III, clinical, radiological and biochemical differentiation between autosomal dominant OI caused by collagen type 1 mutations and autosomal recessive OI caused by CRTAP mutations proves difficult. Therefore, it is important to carry out biochemical analysis in combination with preferably genomic and complementary DNA sequencing of the collagen type I genes in individuals affected with lethal or severe OI. Posttranslational overmodification without collagen type I mutations should prompt CRTAP or LEPRE1 mutation analysis. This approach is important for providing accurate recurrence risk, prenatal diagnosis and preimplantation genetic diagnosis. Moreover, therapeutic options might differ in the future. Furthermore, knowledge of the proportion of cases of lethal and severe OI with recurrence due to CRTAP and LEPRE1 mutations will lead to a more accurate estimation of recurrence risk due to germline mutations in the collagen type I genes. It may very well be that the greater part of the empirical recurrence risk in OI type II and III, currently estimated at 6% for OI type II, 9 can be attributed to autosomal recessive causes.
